Chronic graft versus host disease (cGVHD) is a condition that can occur after a stem cell or bone marrow transplant. It occurs when the donor cells attack the recipient's organs and tissues. Symptoms can include skin rashes, joint pain, dry eyes, and difficulty breathing. Treatment typically involves immunosuppressive medications and other therapies.

1. Dry, itchy skin
2. Fatigue
3. Diarrhea
4. Nausea and vomiting
5. Abdominal pain
6. Weight loss
7. Joint pain
8. Shortness of breath
9. Fever
10. Anemia
11. Liver problems
12. Increased risk of infection
13. Increased risk of developing certain types of cancer
14. Eye problems, such as dryness, irritation, and blurred vision

1. Inadequate immunosuppression
2. Incompatible donor and recipient
3. High intensity of the conditioning regimen
4. Age of the recipient
5. Genetic factors
6. Infections
7. Immune dysregulation
8. Graft-versus-host reaction
9. Inflammation
10. Toxicity of drugs used to treat GVHD

1. Immunosuppressive medications: These medications suppress the immune system and help reduce inflammation. Examples include corticosteroids, cyclosporine, tacrolimus, sirolimus, and mycophenolate mofetil.

2. Antibiotics: These medications are used to treat infections that can occur as a result of chronic GVHD.

3. Biologic agents: These medications are used to target specific parts of the immune system that are causing inflammation. Examples include rituximab, tocilizumab, and infliximab.

4. Photopheresis: This is a procedure in which a patient’s blood is removed, exposed to ultraviolet light, and then returned to the patient. This helps to reduce inflammation.

5. Nutritional support: This

1. Older age
2. Higher intensity of the conditioning regimen
3. Higher doses of immunosuppressive drugs
4. Female gender
5. Higher levels of donor T-cell chimerism
6. Higher levels of donor-derived natural killer cells
7. Higher levels of donor-derived CD4+ T-cells
8. Higher levels of donor-derived CD8+ T-cells
9. Higher levels of donor-derived B-cells
10. Higher levels of donor-derived monocytes
11. Higher levels of donor-derived neutrophils
12. Higher levels of donor-derived eosinophils
13. Higher levels of donor-derived basophils
14. Higher levels of donor-derived NK cells
15. Higher levels of donor-derived CD4+CD25+ T-cells

Yes, there are medications and treatments available for chronic graft versus host disease (cGVHD). These include corticosteroids, calcineurin inhibitors, mycophenolate mofetil, and other immunosuppressive drugs. Additionally, there are other treatments such as photopheresis, plasmapheresis, and stem cell transplantation that may be used to treat cGVHD.